Traws Pharma, Inc.

Historical 13F Holders

Symbol
TRAW
CUSIP
68232V884
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 68232V884 since 12/18/2024, largest first.

Filer % of Class Filed
Orbimed Advisors LLC 13D/A
11.9% 5/5/2026
Event 4/16/2026
Sirenia Capital Management LP 13G
9.9% 8/14/2026
Event 6/30/2026
Alyeska Investment Group, L.P. 13G
9.9% 2/14/2025
Event 12/31/2024
Ikarian Capital, LLC 13G/A
9.5% 8/14/2026
Event 6/30/2026
Chernett Jorey 13G 6.8% 1/16/2026
Event 1/14/2026
Perceptive Advisors LLC 13G/A
6.1% 5/15/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Adage Capital Management, L.P. 13G/A
4.8% 8/12/2026
Event 6/30/2026
Ayrton Capital LLC 13G/A
4.3% 2/11/2026
Event 12/31/2025
Squadron Capital Management LLC 13G/A
0% 8/14/2026
Event 6/30/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 33 6.16 M $5.19 M
2026 Q1 28 3.62 M $6.62 M
2025 Q4 22 3.42 M $3.86 M
2025 Q3 18 1.30 M $2.41 M
2025 Q2 20 1.26 M $1.87 M
2025 Q1 19 1.73 M $3.98 M
2024 Q4 19 1.17 M $10.2 M
2024 Q3 12 646 k $3.80 M